Product How it works Pricing Blog FAQ About Contact
Arkema

Arkema (EPA: AKE) financial statements

The consolidated income statement, balance sheet and cash flow statement of Arkema for its last 7 fiscal years, as filed with the regulator, in millions of euros. At the end of fiscal 2025 it had €14,245m in total assets and €6,843m in equity.

Income statement

Item2025202420232022202120202019
Revenue€9,068m€9,544m€9,514m€11,550m€9,519m€7,884m€8,738m
Operating profit€288.0m€586.0m€681.0m€1,287m€1,733m€600.0m€806.0m
Income tax€100.0m€150.0m€177.0m€254.0m€369.0m€178.0m€137.0m
Net profit€63.0m€354.0m€418.0m€965.0m€1,309m€332.0m€543.0m
Earnings per share€0.52€4.51€5.39€12.81€17.15€3.98€6.45
Diluted earnings per share€0.51€4.49€5.36€12.75€17.04€3.96€6.41

Balance sheet

Item2025202420232022202120202019
Total assets€14,245m€15,209m€14,517m€13,511m€12,301m€10,711m€10,977m
Current assets€4,825m€4,995m€4,858m€4,762m€5,385m€4,063m€4,017m
Inventories€1,142m€1,348m€1,208m€1,399m€1,283m€881.0m€1,014m
Property, plant and equipment—€4,227m€3,730m€3,429m€3,031m€2,828m€3,026m
Goodwill€2,865m€3,071m€3,040m€2,655m€1,925m€1,933m€1,917m
Cash€2,188m€2,013m€2,045m€1,592m€2,285m€1,587m€1,407m
Current liabilities€2,260m€2,486m€2,079m€2,410m€1,993m€1,580m€2,026m
Equity€6,843m€7,526m€7,203m€7,300m€6,303m€5,187m€5,273m
Equity including minorities€7,032m€7,761m€7,455m€7,339m€6,350m€5,235m€5,324m
Minority interests€189.0m€235.0m€252.0m€39.0m€47.0m€48.0m€51.0m

Cash flow statement

Item2025202420232022202120202019
Operating cash flow€997.0m€1,121m€1,272m€1,496m€915.0m€1,115m€1,300m
Investing cash flow−€616.0m−€940.0m−€1,355m−€2,341m€473.0m−€458.0m−€1,362m
Financing cash flow−€286.0m−€207.0m€516.0m€168.0m−€652.0m−€535.0m€64.0m

Where each figure comes from

From the annual report Arkema files every year in the European single electronic format (ESEF). The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. If an item is not tagged in the filing, it is not in the table. The summary of the last fiscal year is on the Arkema page.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.